SCHEMBL21882080

SCHEMBL21882080

CC(C)(C)OC(=O)NC1CCN(NC(=O)c2ccc3cc(Cl)ccc3n2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATF4 P18848 8/20 0.59
HTR7 P34969 1/20 0.44
CKS1B P61024 1/20 0.41
SKP1 P63208 1/20 0.41
SKP2 Q13309 1/20 0.41
CNR1 P21554 2/20 0.40
CNR2 P34972 2/20 0.40
CACNB4 O00305 1/20 0.40
CACNA1A O00555 1/20 0.40
CACNA1G O43497 1/20 0.40
CACNG3 O60359 1/20 0.40
CACNA1F O60840 1/20 0.40
CACNA1H O95180 1/20 0.40
CACNB3 P54284 1/20 0.40
CACNA2D1 P54289 1/20 0.40
CACNG7 P62955 1/20 0.40
CACNA1B Q00975 1/20 0.40
CACNA1D Q01668 1/20 0.40
CACNB1 Q02641 1/20 0.40
CACNG1 Q06432 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29436919 1.00 ATF4 (0.59) ATF4HTR7CKS1BSKP1SKP2
SCHEMBL28516457 0.88 ATF4 (0.49) ATF4HTR7CNR1
SCHEMBL24225655 0.88 ATF4 (0.49) ATF4HTR7CNR1
SCHEMBL29354666 0.88 ATF4 (0.49) ATF4HTR7CNR1
SCHEMBL23920506 0.86 ATF4 (0.51) ATF4CKS1BSKP1SKP2
SCHEMBL21819743 0.85 ATF4 (0.63) ATF4HTR7CNR1CNR2
SCHEMBL21882367 0.84 TRPA1 (0.48) ATF4CKS1BSKP1SKP2CNR1
SCHEMBL29437004 0.84 TRPA1 (0.48) ATF4CKS1BSKP1SKP2CNR1
SCHEMBL21384310 0.82 CNR1 (0.53) ATF4HTR7CNR1CNR2
SCHEMBL21819619 0.82 BACE1 (0.52) ATF4CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11166942-B2 Inhibitors of integrated stress response pathway Praxis Biotech LLC (US) 2021-11-09 US disclosed
CN-112912082-A Integrated stress pathway inhibitors 普拉西斯生物技术有限责任公司 2021-06-04 CN disclosed
US-20200101047-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY Praxis Biotech LLC 2020-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11166942-B2 Inhibitors of integrated stress response pathway ATF4, DDIT3, ATF1 ATF4 1/4885HTR7 922/4885CKS1B 388/4885
US-20200101047-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 ATF4 1/4885HTR7 922/4885CKS1B 388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.